Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

AMS:CTAC - Euronext Amsterdam - NL0000345577 - Common Stock - Currency: EUR

3.4  +0.01 (+0.29%)

Fundamental Rating

6

Overall CTAC gets a fundamental rating of 6 out of 10. We evaluated CTAC against 70 industry peers in the IT Services industry. CTAC has an average financial health and profitability rating. CTAC is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make CTAC a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CTAC was profitable.
In the past year CTAC had a positive cash flow from operations.
In the past 5 years CTAC has always been profitable.
CTAC had a positive operating cash flow in each of the past 5 years.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

CTAC has a Return On Assets of 5.43%. This is in the better half of the industry: CTAC outperforms 67.14% of its industry peers.
Looking at the Return On Equity, with a value of 12.67%, CTAC is in line with its industry, outperforming 55.71% of the companies in the same industry.
The Return On Invested Capital of CTAC (7.73%) is comparable to the rest of the industry.
CTAC had an Average Return On Invested Capital over the past 3 years of 7.76%. This is below the industry average of 10.72%.
Industry RankSector Rank
ROA 5.43%
ROE 12.67%
ROIC 7.73%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CTAC has a Profit Margin (3.14%) which is comparable to the rest of the industry.
CTAC's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 4.47%, CTAC perfoms like the industry average, outperforming 44.29% of the companies in the same industry.
CTAC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.04%, CTAC is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 4.47%
PM (TTM) 3.14%
GM 56.04%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
CTAC has about the same amout of shares outstanding than it did 1 year ago.
CTAC has more shares outstanding than it did 5 years ago.
CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.00 indicates that CTAC is not in any danger for bankruptcy at the moment.
The Altman-Z score of CTAC (3.00) is better than 62.86% of its industry peers.
CTAC has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
CTAC has a Debt to FCF ratio of 1.25. This is amongst the best in the industry. CTAC outperforms 82.86% of its industry peers.
CTAC has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.20, CTAC is in the better half of the industry, outperforming 75.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.25
Altman-Z 3
ROIC/WACC1.16
WACC6.69%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

CTAC has a Current Ratio of 1.01. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.01, CTAC is doing worse than 68.57% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that CTAC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.01, CTAC is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 305.73%, which is quite impressive.
CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
Looking at the last year, CTAC shows a decrease in Revenue. The Revenue has decreased by -2.28% in the last year.
The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)305.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%981.94%
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%0.19%

3.2 Future

The Earnings Per Share is expected to grow by 13.69% on average over the next years. This is quite good.
CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y4.87%
Revenue Next 5Y7.12%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.14, CTAC is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 85.71% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.85. CTAC is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.26, which indicates a very decent valuation of CTAC.
90.00% of the companies in the same industry are more expensive than CTAC, based on the Price/Forward Earnings ratio.
CTAC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.77.
Industry RankSector Rank
PE 12.14
Fwd PE 9.26
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTAC is valued cheaper than 90.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CTAC is valued a bit cheaper than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.87
EV/EBITDA 4.41
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTAC's earnings are expected to grow with 13.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)0.5
EPS Next 2Y30.93%
EPS Next 3Y13.69%

6

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.24%.
CTAC's Dividend Yield is a higher than the industry average which is at 7.37.
Compared to an average S&P500 Dividend Yield of 2.45, CTAC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years2
Div Non Decr Years5
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

CTAC pays out 39.80% of its income as dividend. This is a sustainable payout ratio.
The dividend of CTAC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP39.8%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (4/30/2025, 7:00:00 PM)

3.4

+0.01 (+0.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.27%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap48.11M
Analysts85
Price Target3.83 (12.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP39.8%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-21.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.34%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 9.26
P/S 0.39
P/FCF 6.87
P/OCF 4.68
P/B 1.56
P/tB 11.88
EV/EBITDA 4.41
EPS(TTM)0.28
EY8.24%
EPS(NY)0.37
Fwd EY10.8%
FCF(TTM)0.49
FCFY14.55%
OCF(TTM)0.73
OCFY21.37%
SpS8.79
BVpS2.18
TBVpS0.29
PEG (NY)0.26
PEG (5Y)0.5
Profitability
Industry RankSector Rank
ROA 5.43%
ROE 12.67%
ROCE 14.43%
ROIC 7.73%
ROICexc 10.29%
ROICexgc 140%
OM 4.47%
PM (TTM) 3.14%
GM 56.04%
FCFM 5.63%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexcg growth 3Y-10.84%
ROICexcg growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.25
Debt/EBITDA 0.58
Cap/Depr 63.48%
Cap/Sales 2.64%
Interest Coverage 13.33
Cash Conversion 95.82%
Profit Quality 178.98%
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z 3
F-Score6
WACC6.69%
ROIC/WACC1.16
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)305.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%981.94%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%0.19%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y4.87%
Revenue Next 5Y7.12%
EBIT growth 1Y12.01%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y20.12%
EBIT Next 5YN/A
FCF growth 1Y-21.03%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-3.81%
OCF growth 3Y2.52%
OCF growth 5Y4.91%